Metraipolis › archive › dc_72b600e66ea7

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? — Europe PMC PMID:41008338

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41008338
DOI: 10.3390/brainsci15090978
License (as archived): solo-consultazione
Archived: 2026-11-10T00:08:29.019Z
SHA-256 of the archived text: f58bf742d6a29586963f9f1d42633aea711735ad440d1d0e530dca8bdfc4cf9c
Stable URL of this page: https://metraipolis.com/documento/dc_72b600e66ea7

How to cite

Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? — Europe PMC PMID:41008338 — Europe PMC (en), https://europepmc.org/article/MED/41008338 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_72b600e66ea7 (Metraipolis archive dc_72b600e66ea7, sha256 f58bf742d6a29586963f9f1d42633aea711735ad440d1d0e530dca8bdfc4cf9c)

BibTeX

@misc{dc72b600e66ea7,
  title = {Immunological Targets in Generalized Myasthenia Gravis Treatment: Where Are We Going Now? — Europe PMC PMID:41008338},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41008338},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_72b600e66ea7; sha256 f58bf742d6a29586963f9f1d42633aea711735ad440d1d0e530dca8bdfc4cf9c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41008338. Agents can read the archived copy with the MCP tool read_document.